van Heugten C M, Dekker J, Deelman B G, van Dijk A J, Stehmann-Saris J C, Kinebanian A
Netherlands Institute of Primary Health Care and the Institute for Rehabilitation Research, Hoensbroek.
Clin Rehabil. 1998 Aug;12(4):294-303. doi: 10.1191/026921598674468328.
Evaluation of a therapy programme for stroke patients with apraxia. The programme is based on teaching patients strategies to compensate for the presence of apraxia. This programme was designed for assessment and treatment by occupational therapists.
The outcome was studied in a pre-post test design. Measurements were conducted at baseline and 12 weeks later.
Thirty-three stroke patients with apraxia were treated at occupational therapy departments n general hospitals, rehabilitation centres and nursing homes.
The following measurements were conducted: an apraxia test, a motor functioning test, observation of activities of daily living (ADL), Barthel Index, and an ADL questionnaire for the therapist and the patient.
The patients showed large improvements in ADL functioning on all measures and small improvements on the apraxia test and the motor functioning test. The effect sizes for the disabilities, ranging from 0.92 to 1.06, were large compared to the effect sizes for apraxia (0.34) and motor functioning (0.19). The significant effect of treatment is also seen when individual improvement and subjective improvement are considered. Measured with the Barthel Index for instance, 71% of the patients improved.
These results suggest that the programme seems to be successful in teaching patients compensatory strategies that enable them to function more independently, despite the lasting presence of apraxia.
评估一项针对失用症中风患者的治疗方案。该方案基于教授患者补偿失用症存在的策略。该方案由职业治疗师设计用于评估和治疗。
采用前后测设计研究结果。在基线和12周后进行测量。
33名患有失用症的中风患者在综合医院、康复中心和疗养院的职业治疗科接受治疗。
进行了以下测量:失用症测试、运动功能测试、日常生活活动(ADL)观察、巴氏指数以及针对治疗师和患者的ADL问卷。
患者在所有测量指标上的ADL功能均有大幅改善,在失用症测试和运动功能测试上有小幅改善。与失用症(0.34)和运动功能(0.19)的效应量相比,残疾的效应量在0.92至1.06之间,较大。当考虑个体改善和主观改善时,也可见治疗的显著效果。例如,用巴氏指数测量,71%的患者有所改善。
这些结果表明,该方案似乎成功地教会了患者补偿策略,使他们能够更独立地发挥功能,尽管失用症持续存在。